InvestorsHub Logo
Followers 21
Posts 4905
Boards Moderated 0
Alias Born 05/09/2012

Re: dawgma post# 4181

Friday, 11/11/2016 1:23:28 PM

Friday, November 11, 2016 1:23:28 PM

Post# of 4218
You need to get your facts straight. The Nov 30th meeting you referenced was Nov 30, 2015. They have no meeting scheduled with the FDA as of now. They do not have the money in hand to do the additional clinical trials requested by the FDA last year. Any FDA approval will occur in late 2017 or 2018 if at all. This was dealt with in past earnings conference calls. Wouldn't surprise me if they sell the US rights and concentrate on EU and third world countries and let someone else worry about FDA approval.

And...the time to buy is AFTER the secondary. The only way this company will receive money other than a secondary is if they sell the company outright to an investor...very doubtful at this time. I do know that there have been large investors hoping the company files for bankruptcy so they can buy the ASSETS out of bankruptcy and start clean. That still might happen.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTHP News